# BET inhibitor suppresses melanoma progression <i>via</i> the noncanonical NF-κB/SPP1 pathway

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/bet-inhibitor-suppresses-melanoma-progression-i-via-i-the-noncanonical-nf-b-spp1/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Guangtong Deng,Furong Zeng,Juan Su,Shuang Zhao,Rui Hu,Wu Zhu,Shuo Hu,Xiang Chen,Mingzhu Yin |
| Citations | 142 |
| DOI | 10.7150/thno.47432 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.7150/thno.47432 |
| OpenAlex ID | https://openalex.org/W3088093311 |
| PMID | 33052224 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Juan Su](https://scholariq.org/researchers/juan-su/)

## Paper primary topic

- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

## Paper topics

- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)
- [Ubiquitin and proteasome pathways](https://scholariq.org/topics/ubiquitin-and-proteasome-pathways/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.